Dr. Scott Gottlieb on remdesivir Covid-19 treatment study: 'Results were strong'

Gilead released results Friday morning on its anti-viral drug remdesivir, which was one of the treatments President Trump received as a Covid-19 treatment. Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joins "Squawk Box" to discuss the results of the study.
Fri, Oct 9 20208:34 AM EDT